tenk.fyi

QuidelOrtho Corp

QDELNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$2.7B

1.9% YoY

Net Income

-$1.1B

44.8% YoY

EPS

$-16.69

45.4% YoY

Cash

$169.8M

72.7% YoY

FY 2025 · As of 2025-12-28